Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.

Sponsor:

Information provided by:

Baqiyatallah Medical Sciences University

ClinicalTrials.gov Identifier:

NCT00512811

First received: August 7, 2007

Last updated: NA

Last verified: August 2007

History: No changes posted

Tracking Information

First Received Date ^ICMJE

August 7, 2007

Last Updated Date

August 7, 2007

Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

effect of furosemid inhalation on dyspnea

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Official Title ^ICMJE

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Brief Summary

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Phase 3

Study Design ^ICMJE

Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care

Condition ^ICMJE

Bronchiolitis

Intervention ^ICMJE

Drug: furosemide

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

A contraindication for furosemide use;
An accompanying disease in which other drugs effective for dyspnea were used

Gender

Male

Ages

32 Years to 83 Years

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Iran, Islamic Republic of

Administrative Information

NCT Number ^ICMJE

NCT00512811

Other Study ID Numbers ^ICMJE

121a25

Has Data Monitoring Committee

Yes

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Baqiyatallah Medical Sciences University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Chair:

Mostafa Ghanei, MD

Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran

Information Provided By

Baqiyatallah Medical Sciences University

Verification Date

August 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top